Date/Time
Date(s) - 10/06/2021
2:00 pm CDT - 3:00 pm CDT
Categories
Join us on Wednesday, October 6, 2021 from 2-3 PM CST (3-4PM EST, 1-2PM MT, 12-1PM PST) .
The Foundation for Sarcoidosis Research is thrilled to host Dr. George A. Mensah, Director, Center for Translation Research and Implementation Science, Senior Advisor, Office of the Director, NHLBI, NIH for a webinar focusing on the disproportionate COVID-19 Impact on Communities of Color.
Dr. Mensah’s talk will be focused on addressing the disproportionate impact COVID-19 has had on communities of color, NIH’s efforts to address this through the NIH Community Engagement Alliance (CEAL) Against COVID-19, and the vaccines safety and efficacy.
Please note: This presentation is not meant to address specific sarcoidosis medical questions. But rather share information and resources stemming from the NIH CEAL Against COVID-19, and address the impact on Communities of Color. Specific medical questions regarding sarcoidosis will not be answered during this webinar. If you are seeking sarcoidosis and COVID-19 information, please see FSR’s COVID-19 webpage where you’ll find information and webinars dedicated to this topic.
Register here: https://www.eventbrite.com/e/education-webinar-disproportionate-covid-19-impact-on-communities-of-color-tickets-172885213327
About the expert:
Dr. George Mensah is a clinician-scientist who currently serves as the Director of the Center for Translation Research and Implementation Science at the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health (NIH). In this role, Dr. Mensah leads a trans-NHLBI effort to advance late-stage translational research and implementation science to address gaps in the prevention, treatment, and control of heart, lung, and blood diseases and the elimination of related health inequities. His goal is to maximize the population health impact of advances made in fundamental discovery science and pre-clinical or early-stage translational research. Dr. Mensah is an honors graduate of Harvard University. He obtained his medical degree from Washington University and trained in Internal Medicine and Cardiology at Cornell. His professional experience includes more than 20 years of public health service between the U.S. Department of Veterans Affairs, the Centers for Disease Control and Prevention (CDC), and the NIH. In addition to his public service, Dr. Mensah had 15 years of experience in direct patient care, teaching, and research at Cornell, Vanderbilt, and the Medical College of Georgia (MCG). He was a full professor with tenure at MCG and is currently a Visiting Full Professor at the University of Cape Town, South Africa. Dr. Mensah has been admitted to fellowships in several national and international societies including the American Heart Association, American College of Cardiology, and the European Society of Cardiology. He is an Honorary Fellow of the College of Physicians of South Africa. He maintains active collaboration with several international groups to advance research on the global burden of diseases and risk factors.
Sponsored by Boehringer Ingelheim.
